Загрузка...
Repositioning rifamycins for Mycobacterium abscessus lung disease
INTRODUCTION: The treatment of Mycobacterium abscessus lung disease faces significant challenges due to intrinsic antibiotic resistance. New drugs are needed to cure this incurable disease. The key anti-tubercular rifamycin, rifampicin, suffers from low potency against M. abscessus and is not used c...
Сохранить в:
| Опубликовано в: : | Expert Opin Drug Discov |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6663560/ https://ncbi.nlm.nih.gov/pubmed/31195849 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17460441.2019.1629414 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|